Why the study?
Are plasma levels of cytokines altered in patients with ischemic heart disease compared to controls?
Population
47 individuals (31 patients with ischemic heart disease and 16 controls)
Design
Case-control
Authors
Loading...
These cytokine differences in IHD should not change practice; leaves open causal, biomarker, or therapeutic roles.
Are plasma levels of cytokines altered in patients with ischemic heart disease compared to controls?
Alterations in plasma levels of MCSF (elevated) and TGF-beta (reduced) may be involved in the pathogenesis of ischemic heart disease.
Tashiro et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: